The international magazine Pharma Boardroom offers an interview with the General Director of BioSim, Regina Múzquiz, in which the importance of biosimilars as a tool to alleviate costs for the health system is discussed. In addition, she points to the recent legal proposals on public procurement and the reference pricing system that the association has put forward, and the challenge of convincing doctors that biosimilars are a great opportunity for both patients and the health system. .

READ MORE